U.S. markets open in 2 hours 20 minutes

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
61.51-2.41 (-3.77%)
At close: 04:00PM EDT
61.07 -0.44 (-0.72%)
After hours: 06:35PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close63.92
Bid0.00 x 900
Ask0.00 x 1200
Day's Range60.74 - 64.32
52 Week Range20.63 - 82.00
Avg. Volume965,136
Market Cap2.677B
Beta (5Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-4.67
Earnings DateMay 01, 2023 - May 05, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est107.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for AXSM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Axsome Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 03/28/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • Motley Fool

    3 Up-and-Coming Growth Stocks to Buy Right Now

    Three contributors have ideas on up-and-coming growth stocks to buy right now. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Sarepta Therapeutics (NASDAQ: SRPT), and Travere Therapeutics (NASDAQ: TVTX). Keith Speights (Axsome Therapeutics): Some small drugmakers have all of their eggs in one basket with only one pipeline candidate.

  • Motley Fool

    2 Biotech Stocks That Could Make You Richer

    One is a well-established, large-cap drugmaker, while the other is still making a name for itself in the industry.

  • Motley Fool

    Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money

    There are no guarantees that any stock will generate huge returns. But the odds look pretty good for these three growth stocks.